Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.

[1]  T. van der Poll,et al.  Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees , 1994, The Journal of experimental medicine.

[2]  L. Greenfield,et al.  Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. , 1994, The Journal of thoracic and cardiovascular surgery.

[3]  M. Dehoux,et al.  Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[4]  M. Entman,et al.  Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. , 1994, Cardiovascular research.

[5]  K. Peuhkurinen,et al.  Myocardial Release of Malondialdehyde and Purine Compounds During Coronary Bypass Surgery , 1994, Circulation.

[6]  J. Cavaillon,et al.  Circulating interleukin‐8 concentrations in patients with multiple organ failure of septic and nonseptic origin , 1994, Critical care medicine.

[7]  J. Devière,et al.  Interleukin-10 production during septicaemia , 1994, The Lancet.

[8]  P. Cooper.  Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[9]  P. Menasché,et al.  A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. , 1994, The Journal of thoracic and cardiovascular surgery.

[10]  C. Wanidworanun,et al.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. , 1993, Journal of immunology.

[11]  J. Weiler,et al.  Cytokine and complement levels in patients undergoing cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[12]  D. Das,et al.  Induction of Interleukin‐ 8 Expression During Cardiopulmonary Bypass , 1993, Circulation.

[13]  R. Wakusawa,et al.  Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  L. Casey.  Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.

[15]  L. Bossaert,et al.  Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. , 1993, The American review of respiratory disease.

[16]  S. Davies,et al.  Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[17]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[18]  M. Elliott,et al.  Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[19]  R. Kloner.  Does reperfusion injury exist in humans? , 1993, Journal of the American College of Cardiology.

[20]  D. Abramowicz,et al.  In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A , 1993, The Journal of experimental medicine.

[21]  W. Fiers,et al.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia , 1993, The Journal of experimental medicine.

[22]  B. Griffith,et al.  Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. , 1993, The Annals of thoracic surgery.

[23]  D. Shale,et al.  Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. , 1993, The Journal of thoracic and cardiovascular surgery.

[24]  N. Sheron,et al.  IL‐8 as a circulating cytokine: induction by recombinant tumour necrosis factor‐alpha , 1992, Clinical and experimental immunology.

[25]  S. Westaby,et al.  Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. , 1992, The Annals of thoracic surgery.

[26]  P. Clavien,et al.  Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.

[27]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[28]  A. M. Lefer,et al.  Cardioprotective and endothelial protective effects of [Ala‐IL8]77 in a rabbit model of myocardial ischaemia and reperfusion , 1991, British journal of pharmacology.

[29]  G. Primo,et al.  A survey of nine years heart transplantation at Erasme Hospital, University of Brussels. , 1991, Acta cardiologica.

[30]  L. W. Andersen,et al.  Immunological aspects of cardiopulmonary bypass. , 1990, Journal of cardiothoracic anesthesia.

[31]  A. Carpentier,et al.  Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[32]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, Thorax.

[33]  N. Shumway,et al.  Studies on orthotopic homotransplantation of the canine heart. , 1960, Surgical forum.